| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-26688-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-26203-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-26686-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-26684-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-54577-100ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-26676-50ul | |||
![ELISA: Human APRIL/TNFSF13 ELISA Kit (Colorimetric) [NBP1-82419] - Representative standard curve for human APRIL ELISA. Human APRIL was diluted in serial 2-fold steps in Sample Diluent. Do not use this standard curve to derive test results. A standard curve must be run for each group of microwell strips assayed.](http://images.novusbio.com/fullsize/Human-APRIL-TNFSF13-ELISA-Kit-Colorimetric-ELISA-NBP1-82419-img0001.jpg "ELISA: Human APRIL/TNFSF13 ELISA Kit (Colorimetric) [NBP1-82419] - Representative standard curve for human APRIL ELISA. Human APRIL was diluted in serial 2-fold steps in Sample Diluent. Do not use this standard curve to derive test results. A standard curve must be run for each group of microwell strips assayed.")
![ELISA: IL-21 ELISA Kit [NBP1-84816] - Standard curve](http://images.novusbio.com/fullsize/IL-21-ELISA-Kit-ELISA-NBP1-84816-img0001.jpg "ELISA: IL-21 ELISA Kit [NBP1-84816] - Standard curve")
![Flow Cytometry: CCR8 Antibody (2C10) [NBP3-26688] - Untransfected CHO-K1 cells (green line) and transfected Human CCR8 CHO-K1 stable cells (red line) were stained with anti-CCR8 antibody (2ug/1*10^6 cells), washed and then followed by FITC-conjugated anti-Human IgG Fc antibody and analyzed with flow cytometry.](http://images.novusbio.com/fullsize/nbp3-26688_human-ccr8-mab-2c10-282202414183623.jpg "Flow Cytometry: CCR8 Antibody (2C10) [NBP3-26688] - Untransfected CHO-K1 cells (green line) and transfected Human CCR8 CHO-K1 stable cells (red line) were stained with anti-CCR8 antibody (2ug/1*10^6 cells), washed and then followed by FITC-conjugated anti-Human IgG Fc antibody and analyzed with flow cytometry.")
![ELISA: Human OX40/TNFRSF4 ELISA Kit (Colorimetric) [NBP2-22043]](http://images.novusbio.com/fullsize/Human-OX40-TNFRSF4-ELISA-Kit-Colorimetric-ELISA-NBP2-22043-img0001.jpg "ELISA: Human OX40/TNFRSF4 ELISA Kit (Colorimetric) [NBP2-22043]")
![Flow Cytometry: IL12B Antibody (10B10) [NBP3-26203] - Overlay Peak curve showing A549 cells stained with IL12B Antibody (10B10) (red line) at 1:50. The cells were fixed in 4% formaldehyde and permeated by 0.2% Triton X-100. Then 10% normal goat serum to block non-specific protein-protein interactions followed by the antibody (1ug/1*10^6 cells) for 45min at 4C. The secondary antibody used was FITC-conjugated Goat Anti-rabbit IgG (H+L) at 1:200 dilution for 35min at 4C. Control antibody (green line) was rabbit IgG (1ug/1*10^6 cells) used under the same conditions. Acquisition of >10,000 events was performed.](http://images.novusbio.com/fullsize/nbp3-26203_rabbit-il12b-mab-10b10-28220241431278.jpg "Flow Cytometry: IL12B Antibody (10B10) [NBP3-26203] - Overlay Peak curve showing A549 cells stained with IL12B Antibody (10B10) (red line) at 1:50. The cells were fixed in 4% formaldehyde and permeated by 0.2% Triton X-100. Then 10% normal goat serum to block non-specific protein-protein interactions followed by the antibody (1ug/1*10^6 cells) for 45min at 4C. The secondary antibody used was FITC-conjugated Goat Anti-rabbit IgG (H+L) at 1:200 dilution for 35min at 4C. Control antibody (green line) was rabbit IgG (1ug/1*10^6 cells) used under the same conditions. Acquisition of >10,000 events was performed.")
![ELISA: IL-12 ELISA Kit [Biotin] [NBP1-92677] - Standard curve](http://images.novusbio.com/fullsize/IL-12-ELISA-Kit-[Biotin]-ELISA-NBP1-92677-img0001.jpg "ELISA: IL-12 ELISA Kit [Biotin] [NBP1-92677] - Standard curve")
![Flow Cytometry: CCR8 Antibody (2C6) [NBP3-26686] - Untransfected HEK293T cells (green line) and transfected Human CCR8 HEK293T stable cells (red line) were stained with anti-CCR8 antibody (2ug/1*10^6 cells), washed and then followed by FITC-conjugated anti-Human IgG Fc antibody and analyzed with flow cytometry.](http://images.novusbio.com/fullsize/nbp3-26686_human-ccr8-mab-2c6-28220241431276.jpg "Flow Cytometry: CCR8 Antibody (2C6) [NBP3-26686] - Untransfected HEK293T cells (green line) and transfected Human CCR8 HEK293T stable cells (red line) were stained with anti-CCR8 antibody (2ug/1*10^6 cells), washed and then followed by FITC-conjugated anti-Human IgG Fc antibody and analyzed with flow cytometry.")
![Flow Cytometry: CD3 zeta Antibody (21H6) [NBP3-26684] - Overlay Peak curve showing Jurkat cells stained with CD3 zeta Antibody (21H6) (red line) at 1:50. The cells were fixed in 4% formaldehyde and permeated by 0.2% Triton X-100. Then 10% normal goat serum to block non-specific protein-protein interactions followed by the antibody (1ug/1*10^6 cells) for 45min at 4C. The secondary antibody used was FITC-conjugated Goat Anti-rabbit IgG (H+L) at 1:200 dilution for 35min at 4C. Control antibody (green line) was rabbit IgG (1ug/1*10^6 cells) used under the same conditions. Acquisition of >10,000 events was performed.](http://images.novusbio.com/fullsize/nbp3-26684_rabbit-cd3-zeta-mab-21h6-282202414312735.jpg "Flow Cytometry: CD3 zeta Antibody (21H6) [NBP3-26684] - Overlay Peak curve showing Jurkat cells stained with CD3 zeta Antibody (21H6) (red line) at 1:50. The cells were fixed in 4% formaldehyde and permeated by 0.2% Triton X-100. Then 10% normal goat serum to block non-specific protein-protein interactions followed by the antibody (1ug/1*10^6 cells) for 45min at 4C. The secondary antibody used was FITC-conjugated Goat Anti-rabbit IgG (H+L) at 1:200 dilution for 35min at 4C. Control antibody (green line) was rabbit IgG (1ug/1*10^6 cells) used under the same conditions. Acquisition of >10,000 events was performed.")
![Flow Cytometry: CD59 Antibody (28D4) [NBP3-26676] - Overlay Peak curve showing Hela cells stained with CD59 Antibody (28D4) (red line) at 1:50. The cells were fixed in 4% formaldehyde and permeated by 0.2% Triton X-100. Then 10% normal goat serum to block non-specific protein-protein interactions followed by the antibody (1ug/1*10^6 cells) for 45min at 4C. The secondary antibody used was FITC-conjugated Goat Anti-rabbit IgG (H+L) at 1:200 dilution for 35min at 4C. Control antibody (green line) was rabbit IgG (1ug/1*10^6 cells) used under the same conditions. Acquisition of >10,000 events was performed.](http://images.novusbio.com/fullsize/nbp3-26676_rabbit-cd59-mab-28d4-282202414183671.jpg "Flow Cytometry: CD59 Antibody (28D4) [NBP3-26676] - Overlay Peak curve showing Hela cells stained with CD59 Antibody (28D4) (red line) at 1:50. The cells were fixed in 4% formaldehyde and permeated by 0.2% Triton X-100. Then 10% normal goat serum to block non-specific protein-protein interactions followed by the antibody (1ug/1*10^6 cells) for 45min at 4C. The secondary antibody used was FITC-conjugated Goat Anti-rabbit IgG (H+L) at 1:200 dilution for 35min at 4C. Control antibody (green line) was rabbit IgG (1ug/1*10^6 cells) used under the same conditions. Acquisition of >10,000 events was performed.")